ANI Pharmaceuticals (STU:BSFA) Change In Inventory: €-3.9 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:BSFA ANI Pharmaceuticals Inc STU:BSFA
86 GF Score
Price €61.00
GF Value €83.83
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is ANI Pharmaceuticals Change In Inventory?

ANI Pharmaceuticals STU:BSFA -0.81% 86 Change In Inventory is €-3.9 Mil as of Jun. 2026. GuruFocus rates STU:BSFA with a GF Score™ of 86/100 and a GF Value™ of €83.83 (Modestly Undervalued). The stock has 2 warning signs investors should review.

ANI Pharmaceuticals's change in inventory for the quarter that ended in Jun. 2026 was €0.3 Mil. It means ANI Pharmaceuticals's inventory declined by €0.3 Mil from Mar. 2026 to Jun. 2026 .

ANI Pharmaceuticals's change in inventory for the fiscal year that ended in Dec. 2025 was €-5.1 Mil. It means ANI Pharmaceuticals's inventory increased by €5.1 Mil from Dec. 2024 to Dec. 2025 .

ANI Pharmaceuticals's Total Inventories for the quarter that ended in Jun. 2026 was €124.3 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. ANI Pharmaceuticals's Days Inventory for the quarter that ended in Jun. 2026 was 130.34.

Inventory Turnover measures how fast the company turns over its inventory within a year. ANI Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.70.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. ANI Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.54.

ANI Pharmaceuticals  (STU:BSFA) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

ANI Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=124.1765/86.937*365 / 4
=130.34

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

ANI Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=86.937 / 124.1765
=0.70

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

ANI Pharmaceuticals's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=124.1765 / 230.926
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ANI Pharmaceuticals Change In Inventory Related Terms

ANI Pharmaceuticals Change In Inventory Historical Data

* Premium members only.

The historical data trend for ANI Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ANI Pharmaceuticals Change In Inventory Chart

ANI Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.85 -22.30 -5.36 -20.33 -5.09

ANI Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.79 -6.95 3.19 -0.38 0.27
STU:BSFA
86GF Score
ANI Pharmaceuticals Inc STU:BSFA
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ANI Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of €-3.9 Mil mean?
ANI Pharmaceuticals (STU:BSFA) has a Change In Inventory of €-3.9 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for ANI Pharmaceuticals and its competitors.
Is ANI Pharmaceuticals' Change In Inventory too high?
ANI Pharmaceuticals' current Change In Inventory is €-3.9 Mil. Overall, ANI Pharmaceuticals has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ANI Pharmaceuticals' Change In Inventory compare to ETON and ALVO?
ANI Pharmaceuticals' Change In Inventory of €-3.9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for ANI Pharmaceuticals and its competitors. ANI Pharmaceuticals's current Change In Inventory is €-3.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ANI Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, ANI Pharmaceuticals (STU:BSFA) is currently considered Modestly Undervalued. The stock's GF Value™ is €83.83, compared to a current price of €61.00 — trading 27.2% below its estimated fair value. The current Change In Inventory is €-3.9 Mil. ANI Pharmaceuticals' overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For ANI Pharmaceuticals (STU:BSFA), the current Change In Inventory is €-3.9 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ANI Pharmaceuticals (STU:BSFA) Overvalued in 2026?

Based on GuruFocus' analysis, ANI Pharmaceuticals stock appears to be undervalued. The current stock price of €61.00 is trading 27.2% below its estimated GF Value™ of €83.83. GuruFocus considers ANI Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for STU:BSFA:

  • Change In Inventory: €-3.9 Mil
  • GF Value™: €83.83 vs. price of €61.00 (27.2% below fair value)
  • GF Score™: 86/100 with 2 warning signs

No single metric tells the full story. See the STU:BSFA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ANI Pharmaceuticals Business Description

Other Exchanges ANIP:USABSFA:Germany
Address 210 Main Street West, Baudette, MN, USA, 56623
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
86GF Score

Get the complete analysis for STU:BSFA

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€61.00
Price
€83.83
GF Value